SectorBiological Technology
Established Date23/01/2004
Listing Date08/07/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees10
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressSuite 200
1920 Yonge Street Toronto
Ontario M4S 3E2
Business
IntroductionProMIS Neurosciences Inc., was incorporated on January 23, 2004 under the Canadian Business Corporations Act. The company has been licensed a patented technology platform focusing on the development of antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases. Its platform is designed to selectively target toxic misfolded proteins associated with diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
